OTCMKTS:GBLX

GB Sciences Competitors

$0.05
0.00 (0.00 %)
(As of 04/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.05
Now: $0.05
$0.05
50-Day Range
$0.05
MA: $0.06
$0.08
52-Week Range
$0.02
Now: $0.05
$0.13
Volume149,315 shs
Average Volume822,223 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

GB Sciences (OTCMKTS:GBLX) Vs. IIPR, GRWG, XXII, KSHB, NSAV, and TRTC

Should you be buying GBLX stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to GB Sciences, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), NSAV (NSAV), and Terra Tech (TRTC).

Innovative Industrial Properties (NYSE:IIPR) and GB Sciences (OTCMKTS:GBLX) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for Innovative Industrial Properties and GB Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innovative Industrial Properties02502.71
GB Sciences0000N/A

Innovative Industrial Properties currently has a consensus price target of $192.4286, suggesting a potential upside of 6.95%. Given Innovative Industrial Properties' higher probable upside, equities analysts plainly believe Innovative Industrial Properties is more favorable than GB Sciences.

Earnings & Valuation

This table compares Innovative Industrial Properties and GB Sciences' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Industrial Properties$44.67 million96.37$23.48 million$3.2755.02
GB SciencesN/AN/AN/AN/AN/A

Innovative Industrial Properties has higher revenue and earnings than GB Sciences.

Insider & Institutional Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Innovative Industrial Properties and GB Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innovative Industrial Properties55.71%6.05%4.82%
GB SciencesN/AN/AN/A

Summary

Innovative Industrial Properties beats GB Sciences on 8 of the 8 factors compared between the two stocks.

GrowGeneration (NASDAQ:GRWG) and GB Sciences (OTCMKTS:GBLX) are both basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for GrowGeneration and GB Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GrowGeneration03502.63
GB Sciences0000N/A

GrowGeneration currently has a consensus price target of $49.5714, suggesting a potential upside of 8.21%. Given GrowGeneration's higher probable upside, equities analysts plainly believe GrowGeneration is more favorable than GB Sciences.

Earnings & Valuation

This table compares GrowGeneration and GB Sciences' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GrowGeneration$79 million33.90$1.88 million$0.10458.10
GB SciencesN/AN/AN/AN/AN/A

GrowGeneration has higher revenue and earnings than GB Sciences.

Insider & Institutional Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares GrowGeneration and GB Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GrowGeneration2.14%4.68%3.53%
GB SciencesN/AN/AN/A

Summary

GrowGeneration beats GB Sciences on 8 of the 8 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and GB Sciences (OTCMKTS:GBLX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for 22nd Century Group and GB Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
22nd Century Group00103.00
GB Sciences0000N/A

Earnings & Valuation

This table compares 22nd Century Group and GB Sciences' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
22nd Century GroupN/AN/AN/AN/AN/A
GB SciencesN/AN/AN/AN/AN/A

Profitability

This table compares 22nd Century Group and GB Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
22nd Century GroupN/AN/AN/A
GB SciencesN/AN/AN/A

Summary

22nd Century Group beats GB Sciences on 1 of the 1 factors compared between the two stocks.

KushCo (OTCMKTS:KSHB) and GB Sciences (OTCMKTS:GBLX) are both multi-sector conglomerates companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for KushCo and GB Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
KushCo01302.75
GB Sciences0000N/A

KushCo currently has a consensus price target of $1.8750, suggesting a potential upside of 75.23%. Given KushCo's higher probable upside, equities analysts plainly believe KushCo is more favorable than GB Sciences.

Earnings & Valuation

This table compares KushCo and GB Sciences' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KushCo$113.84 million1.49$-77,660,000.00($0.68)-1.57
GB SciencesN/AN/AN/AN/AN/A

GB Sciences has lower revenue, but higher earnings than KushCo.

Insider & Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares KushCo and GB Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
KushCo-65.89%-47.95%-31.39%
GB SciencesN/AN/AN/A

Summary

KushCo beats GB Sciences on 5 of the 8 factors compared between the two stocks.

NSAV (OTCMKTS:NSAV) and GB Sciences (OTCMKTS:GBLX) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current recommendations and price targets for NSAV and GB Sciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NSAV0000N/A
GB Sciences0000N/A

Earnings and Valuation

This table compares NSAV and GB Sciences' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NSAVN/AN/AN/AN/AN/A
GB SciencesN/AN/AN/AN/AN/A

Profitability

This table compares NSAV and GB Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NSAVN/AN/AN/A
GB SciencesN/AN/AN/A

Terra Tech (OTCMKTS:TRTC) and GB Sciences (OTCMKTS:GBLX) are both industrial products companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current recommendations and price targets for Terra Tech and GB Sciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Terra Tech0000N/A
GB Sciences0000N/A

Earnings and Valuation

This table compares Terra Tech and GB Sciences' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Terra Tech$28.05 million2.40$-46,930,000.00N/AN/A
GB SciencesN/AN/AN/AN/AN/A

GB Sciences has lower revenue, but higher earnings than Terra Tech.

Institutional & Insider Ownership

0.1% of Terra Tech shares are held by institutional investors. 6.7% of Terra Tech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Terra Tech and GB Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Terra Tech-261.88%-110.38%-62.41%
GB SciencesN/AN/AN/A


GB Sciences Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Innovative Industrial Properties logo
IIPR
Innovative Industrial Properties
1.8$179.93flat$4.24 billion$44.67 million58.23Analyst Revision
News Coverage
GrowGeneration logo
GRWG
GrowGeneration
1.5$45.81flat$2.68 billion$79 million916.38
22nd Century Group logo
XXII
22nd Century Group
0.9$4.00flat$569.97 millionN/A0.00Unusual Options Activity
News Coverage
KushCo logo
KSHB
KushCo
1.3$1.07flat$166.81 million$113.84 million-1.78
NSAV logo
NSAV
NSAV
0.3$0.02flat$94.56 millionN/A0.00
Terra Tech logo
TRTC
Terra Tech
0.7$0.29flat$66.63 million$28.05 million0.00Gap Up
General Cannabis logo
CANN
General Cannabis
0.6$0.84flat$51.58 million$3.67 million0.00Gap Down
Grow Capital logo
GRWC
Grow Capital
0.6$1.23flat$27.07 million$2.37 million0.00Gap Up
PVSP
Pervasip
0.4$0.00flat$24.75 millionN/A0.00Increase in Short Interest
Gap Down
NMUS
Nemus Bioscience
0.6$0.12flat$15.94 millionN/A0.00High Trading Volume
Leafbuyer Technologies logo
LBUY
Leafbuyer Technologies
0.5$0.14flat$12.37 million$2.53 million0.00
MassRoots logo
MSRT
MassRoots
0.6$0.02flat$10.55 million$20,000.000.00Gap Down
Peak Pharmaceuticals logo
PKPH
Peak Pharmaceuticals
0.7$0.10flat$8.42 millionN/A0.00Gap Up
FutureWorld logo
FWDG
FutureWorld
0.5$0.00flat$4.56 millionN/A0.00
NGBL
Notis Global
0.5$0.00flat$3.00 millionN/A0.00
Mentor Capital logo
MNTR
Mentor Capital
0.5$0.13flat$2.97 million$4.33 million-3.33News Coverage
Gap Down
DigiPath logo
DIGP
DigiPath
0.5$0.04flat$2.73 million$2.55 million-1.33Gap Up
CrowdGather logo
CRWG
CrowdGather
0.7$0.01flat$1.38 million$160,000.000.00
United Cannabis logo
CNAB
United Cannabis
0.4$0.01flat$1.17 millionN/A0.00Gap Up
OPMZ
1PM Industries
0.4$0.00flat$0.00N/A0.00
AQSP
Acquired Sales
0.4$6.00flat$0.00N/A0.00
AMMJ
American Cannabis
0.5$0.18flat$0.00N/A0.00Gap Up
AmeriCann logo
ACAN
AmeriCann
0.4$1.22flat$0.00N/A0.00
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.20flat$0.00N/A0.00News Coverage
Cannabis Sativa logo
CBDS
Cannabis Sativa
0.5$0.67flat$0.00N/A0.00News Coverage
FRLF
Freedom Leaf
0.5$0.01flat$0.00N/A0.00High Trading Volume
Gap Up
FUTL
FutureLand
0.4$0.00flat$0.00N/A0.00News Coverage
GreenGro Technologies logo
GRNH
GreenGro Technologies
0.6$0.02flat$0.00N/A0.00
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.86flat$0.00N/A0.00Gap Up
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01flat$0.00N/A0.00Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05flat$0.00N/A0.00News Coverage
Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00Gap Up
MDCL
Medicine Man Technologies
0.5$2.43flat$0.00N/A0.00
Northsight Capital logo
NCAP
Northsight Capital
0.5$0.00flat$0.00N/A0.00Gap Down
OWC Pharmaceutical Research logo
OWCP
OWC Pharmaceutical Research
0.6$0.01flat$0.00N/A0.00Gap Up
Surna logo
SRNA
Surna
0.6$0.06flat$0.00N/A0.00Gap Down
Ultrack Systems logo
MJLB
Ultrack Systems
0.6$0.07flat$0.00N/A0.00Gap Down
BUDZ
WEED
0.6$0.53flat$0.00N/A0.00Gap Down
Zoned Properties logo
ZDPY
Zoned Properties
0.6$0.54flat$0.00N/A0.00Gap Up
ZZLL
ZZLL Information Technology
0.4$0.25flat$0.00N/A0.00
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.